On January 30th, in a landmark decision that could reshape the way acute pain is treated in the United States, the FDA
opioid analgesics
“The world’s largest review on opioid medicines for cancer pain has found it is unclear whether some commonly used opioid medicines are better than a placebo and suggests that nonopioid medicines, including aspirin, may b